Influx Healthtech Ltd. Achieves Tanzania TBS Certification, Strengthening Its Global Nutraceutical Footprint

  • Home
  • News Centres
  • Influx Healthtech Ltd. Achieves Tanzania TBS Certification, Strengthening Its Global Nutraceutical Footprint

Influx Healthtech Ltd., is a leading Contract Development and Manufacturing Organization (CDMO) in the nutraceutical, cosmeceutical, and veterinary supplement sector, has achieved a significant international milestone by receiving approval from the Tanzania Bureau of Standards (TBS) for its nutraceutical manufacturing operations.

This accomplishment places Influx Healthtech among the few Indian companies to obtain Tanzania’s TBS certification in the nutraceutical category, reinforcing its commitment to expanding into international markets and building a strong global presence.

About Tanzania Bureau of Standards (TBS)

The Tanzania Bureau of Standards is the national standards body of the Tanzania, responsible for regulating product quality, safety, and compliance for goods entering the Tanzanian market. TBS ensures that products meet strict technical standards related to manufacturing practices, labeling, safety, and quality before they are allowed to be marketed or distributed within the country.

For nutraceutical manufacturers, obtaining TBS approval requires stringent documentation, quality assurance, manufacturing compliance, and adherence to internationally accepted production standards.

A Strategic Step Toward Global Expansion

Receiving the TBS certification reflects Influx Healthtech Ltd.’s strategic vision to expand its footprint in global nutraceutical markets, particularly across emerging regions such as Africa. The approval enables the company to support brands and distributors looking to enter the Tanzanian and East African markets with high-quality nutraceutical products manufactured in India.

This milestone further highlights Influx Healthtech’s growing international regulatory capabilities. The company already operates under globally recognized certifications including FSSC 22000 and NSF International, demonstrating adherence to rigorous food safety and quality management systems.

Additionally, Influx products have received approvals from National Agency for Food and Drug Administration and Control (NAFDAC), enabling access to the Nigerian market, one of Africa’s fastest-growing nutraceutical sectors.

Leadership Perspective

Commenting on the achievement, the Quality Control Head of Department Mr. Anshul Maurya at Influx Healthtech stated that the TBS certification is an important step in the company’s international journey.

“Receiving Tanzania’s TBS approval is a proud moment for our organization. It reflects our commitment and adherance to GMP and hardwork of  our team to maintaining global manufacturing standards and expanding our presence in international markets. Africa is a rapidly growing market for nutraceuticals, and we look forward to supporting brands that aim to serve consumers in these regions with good quality, innovation and science-backed products.”

Building a Global Nutraceutical Manufacturing Hub

With three manufacturing facilities, Good R&D capabilities, and over two decades of industry expertise, Influx Healthtech continues to position itself as a trusted CDMO partner for nutraceutical and health brands worldwide.

The addition of Tanzania’s TBS certification further strengthens the company’s international regulatory portfolio and signals its long-term commitment to becoming a globally recognized Indian nutraceutical manufacturing partner.

As the global demand for preventive healthcare and nutraceutical products continues to grow, Influx Healthtech remains focused on delivering quality, compliance, and innovation while expanding its reach into new international markets.